Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Robin E Ferner"'
Autor:
Hannah L Brooks, Sarah K Pontefract, Hannah K Vallance, Christine A Hirsch, Elizabeth Hughes, Robin E Ferner, John F Marriott, Jamie J Coleman
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168558 (2016)
Junior doctors in the UK must complete various educational components during their two year Foundation training programme. It is important that mandatory learning is informative and engaging. The aim of this study was to evaluate trainee doctors' per
Externí odkaz:
https://doaj.org/article/1bce8203323342b7b5de34ed9ca8ca90
Autor:
Krishnarajah Nirantharakumar, Tom Marshall, James Hodson, Parth Narendran, Jon Deeks, Jamie J Coleman, Robin E Ferner
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40384 (2012)
Background and aimWe wished to establish the frequency of unexpected hypoglycemia observed in non diabetic patients outside the intensive care unit and to determine if they have a plausible clinical explanation.MethodsWe analysed data for 2010 from t
Externí odkaz:
https://doaj.org/article/f35322d4ed1b44fba5c7c87b4291dca2
Autor:
Harrison S. France, Jeffrey K. Aronson, Carl Heneghan, Robin E. Ferner, Anthony R. Cox, Georgia C. Richards
Publikováno v:
Drug Safety. 46:335-342
Autor:
Emma J. Moyns, Robin E. Ferner
Publikováno v:
Diabetic Medicine. 40
Autor:
Robin E Ferner, Julie Mason, Jamie J Coleman, Hannah K. Vallance, Tanvi Choudhary, Sarah Pontefract, John F. Marriott
Publikováno v:
British Journal of Clinical Pharmacology. 88:2437-2440
In response to the COVID-19 pandemic, Health Education England (HEE) and the University of Birmingham provided National Health Service (NHS) staff free access to SCRIPT, a national eLearning programme for safer prescribing and therapeutics. The eLear
Publikováno v:
BMJ Evidence-Based Medicine. 27:60-64
Publikováno v:
British Journal of Clinical Pharmacology. 88:2571-2580
INTRODUCTION: Free-of-charge (FoC) medicine schemes are increasingly available and allow access to investigational treatments outside clinical trials or in advance of licensing or NHS commissioning. METHODS: We retrospectively reviewed FoC medicine s
Autor:
Francesco Dernie, Elizabeth T Thomas, Maja Bilip, Nicholas J. DeVito, Harrison S. France, Robin E. Ferner, Anthony R. Cox, Carl Heneghan, Jeffrey K. Aronson, Georgia C. Richards
BackgroundDeaths from opioids have increased in England and Wales, despite recognition of their harms. Coroners’ Prevention of Future Death reports (PFDs) provide important insights that may enable safer use and avert harms, yet these reports invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1113c0b621b3523ac6ed6230c9e0c8f
https://doi.org/10.1101/2022.11.16.22282411
https://doi.org/10.1101/2022.11.16.22282411
Autor:
Harrison S France, Jeffrey K Aronson, Carl Heneghan, Robin E Ferner, Anthony R Cox, Georgia C Richards
ObjectivesTo identify medicines-related deaths in coroners’ reports and to explore concerns to prevent future deaths.DesignRetrospective case series of coroners’ Prevention of Future Deaths reports (PFDs).SettingEngland and Wales.ParticipantsIndi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b6d9dc1edd903e017ef5037f29a21f6
https://doi.org/10.1101/2022.11.01.22281803
https://doi.org/10.1101/2022.11.01.22281803
Autor:
Robin E. Ferner, Jeffrey K. Aronson
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
The initial purposes of regulation of medicines in England, and latterly in the United Kingdom, were principally to raise government revenue, to discourage murder by poisoning and to regulate the activities of pharmacists. It was only much later that